Recommended IVF Protocol for Normal-Responding Couples
For normal-responding couples undergoing IVF, single embryo transfer (SET) is strongly recommended, particularly when transferring blastocysts, to minimize maternal and fetal complications while maintaining comparable pregnancy success rates. 1
Embryo Transfer Strategy
Blastocyst Stage Transfer
- SET should be applied regardless of blastocyst quality when transferring vitrified-warmed blastocysts 1
- This recommendation is driven by the significantly higher risk of:
- Monozygotic twinning with blastocyst transfer
- Multiple pregnancy complications when transferring two blastocysts
- Up to 20-fold increased ectopic pregnancy risk with multiple embryo transfer 1
Cleavage Stage Transfer
- For cryopreserved-warmed cleavage-stage embryos, the decision between double embryo transfer (DET) versus SET should not be based on embryo quality criteria alone 1
- The evidence shows no clear advantage of DET over SET in normal responders across prognostic factors 1
Ovarian Stimulation Protocol Options
While the provided guidelines focus primarily on embryo transfer numbers, research evidence suggests protocol flexibility for normal responders:
GnRH Antagonist vs. Agonist Protocols
Both protocols yield similar clinical pregnancy and live birth rates in normal responders 2, 3:
GnRH antagonist protocol advantages:
GnRH agonist long protocol:
Gonadotropin Dosing
For normal responders, mild starting dosages (75-150 IU r-FSH) combined with modified prolonged GnRH-agonist protocol may improve outcomes 5:
- Higher fertilization rates (2PN)
- Better embryo quality
- Improved implantation, clinical pregnancy, and live birth rates
- Lower financial cost
- Similar OHSS rates compared to conventional dosing
Critical Counseling Points
Healthcare professionals must discuss with both partners 1:
Medical Risks of Multiple Embryo Transfer
- Maternal pregnancy complications
- Increased ectopic pregnancy risk (up to 20-fold) 1
- Monozygotic twinning risk with blastocysts
- Long-term health consequences for mother and offspring
Decision-Making Framework
- Patient values and personal context
- Family-building goals
- Economic and social factors
- Evidence-based recommendations specific to their case
Common Pitfalls to Avoid
Never transfer two or more embryos with the intention of performing fetal reduction if multiple implantation occurs—this strategy is explicitly not recommended due to high procedural risks 1
Avoid DET in donor oocyte, donated embryo, or gestational carrier cycles at all costs—these scenarios have clearly increased pregnancy complication risks and eSET is strongly recommended 1
Do not base cleavage-stage embryo transfer decisions solely on embryo morphology—the evidence does not support this approach in normal responders 1
Avoid mild stimulation protocols using clomiphene citrate or letrozole in normal responders—these show marginally lower live birth rates compared to conventional antagonist protocols 6
Algorithm for Normal Responders
Step 1: Ovarian Stimulation
- Choose GnRH antagonist protocol for shorter duration and lower medication costs
- OR choose GnRH agonist long protocol if prioritizing slightly higher fresh transfer success
- Consider mild r-FSH starting dose (75-150 IU) with modified prolonged GnRH-agonist protocol
Step 2: Embryo Culture
- Culture to blastocyst stage when possible for better selection
Step 3: Transfer Strategy
- Blastocyst transfer: Always SET (fresh or frozen)
- Cleavage-stage transfer: Strongly consider SET unless multiple poor prognostic factors present
Step 4: Cryopreservation
- Freeze remaining viable embryos for subsequent SET cycles
- This cumulative approach maintains overall pregnancy success while eliminating multiple pregnancy risks
The evidence unequivocally demonstrates that no single prognostic factor in normal responders justifies routine DET over SET when considering maternal and fetal morbidity and mortality 1.